“VENTURE19” DR on Singapore-based healthcare tech company to debut on February 28

Published on 27/02/2024

BANGKOK, February 27, 2024 – The Stock Exchange of Thailand (SET) will list depositary receipt (DR) on Venture Corporation Limited, a Singapore-based technology provider playing a pivotal role in medical industry including laboratory equipment, genetic testing devices, healthcare products; and semiconductor component manufacturer for automated robotic systems in the manufacturing industry and IoT devices. The VENTURE19 DR, issued by Yuanta Securities (Thailand) Co. Ltd. as a part of the cooperative project between SET and SGX Group under “Thailand-Singapore DR Linkage”, will start trading on SET on February 28.


DR is an investment instrument that provides investors with the benefits of the underlying foreign securities by trading DR in Thai baht via the existing securities accounts.


For more information on VENTURE19 DR, please visit or website of the issuer: Yuanta Securities (Thailand) at For additional information on DR, please visit